Tufton Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.6M Sell
98,272
-860
-0.9% -$101K 2.12% 13
2026
Q1
$11.9M Sell
99,132
-1,133
-1% -$131K 2.17% 13
2025
Q4
$10.6M Sell
100,265
-917
-0.9% -$86.1K 1.84% 18
2025
Q3
$8.49M Sell
101,182
-455
-0.4% -$37.5K 1.51% 25
2025
Q2
$8.04M Sell
101,637
-3,160
-3% -$251K 1.53% 25
2025
Q1
$9.41M Buy
104,797
+113
+0.1% +$10.6K 1.81% 18
2024
Q4
$10.4M Buy
104,684
+565
+0.5% +$58.2K 1.97% 12
2024
Q3
$11.8M Sell
104,119
-1,250
-1% -$149K 2.22% 9
2024
Q2
$13M Sell
105,369
-685
-0.6% -$88.2K 2.54% 8
2024
Q1
$14M Sell
106,054
-351
-0.3% -$43.3K 2.75% 7
2023
Q4
$11.6M Sell
106,405
-1,423
-1% -$148K 2.43% 7
2023
Q3
$11.1M Sell
107,828
-513
-0.5% -$55.3K 2.48% 9
2023
Q2
$12.5M Sell
108,341
-3,345
-3% -$380K 2.7% 6
2023
Q1
$11.9M Sell
111,686
-16,456
-13% -$1.78M 2.57% 6
2022
Q4
$14.2M Buy
128,142
+606
+0.5% +$61.9K 3.13% 4
2022
Q3
$11M Sell
127,536
-43,026
-25% -$3.84M 2.65% 5
2022
Q2
$15.6M Sell
170,562
-104
-0.1% -$9.22K 2.9% 6
2022
Q1
$14M Sell
170,666
-2,086
-1% -$164K 2.26% 11
2021
Q4
$13.2M Buy
172,752
+1,946
+1% +$155K 2.03% 14
2021
Q3
$12.8M Sell
170,806
-663
-0.4% -$50.4K 2.17% 9
2021
Q2
$13.3M Sell
171,469
-12,948
-7% -$963K 2.19% 11
2021
Q1
$13.6M Buy
184,417
+3,968
+2% +$293K 2.32% 10
2020
Q4
$14.1M Buy
180,449
+901
+0.5% +$68.9K 2.6% 8
2020
Q3
$14.2M Sell
179,548
-3,919
-2% -$307K 2.94% 5
2020
Q2
$13.5M Buy
183,467
+1,455
+0.8% +$110K 2.98% 4
2020
Q1
$13.4M Buy
182,012
+2,801
+2% +$220K 3.43% 2
2019
Q4
$15.6M Sell
179,211
-1,772
-1% -$146K 3.06% 4
2019
Q3
$14.5M Sell
180,983
-1,265
-0.7% -$101K 3.07% 4
2019
Q2
$14.6M Sell
182,248
-104
-0.1% -$7.96K 3.08% 3
2019
Q1
$14.5M Sell
182,352
-1,418
-0.8% -$106K 3.08% 2
2018
Q4
$13.4M Sell
183,770
-728
-0.4% -$51.4K 3.29% 2
2018
Q3
$12.5M Sell
184,498
-11,530
-6% -$735K 2.66% 6
2018
Q2
$11.4M Sell
196,028
-2,851
-1% -$161K 2.43% 6
2018
Q1
$10.3M Buy
198,879
+2,821
+1% +$152K 2.04% 12
2017
Q4
$10.5M Buy
196,058
+3,210
+2% +$178K 2.03% 12
2017
Q3
$11.8M Buy
192,848
+6,914
+4% +$419K 2.36% 8
2017
Q2
$11.4M Buy
185,934
+1,205
+0.7% +$73.4K 2.31% 9
2017
Q1
$11.2M Sell
184,729
-1,034
-0.6% -$62.7K 2.21% 8
2016
Q4
$10.4M Sell
185,763
-2,546
-1% -$149K 2.12% 10
2016
Q3
$11.2M Sell
188,309
-8,769
-4% -$513K 2.26% 8
2016
Q2
$10.8M Sell
197,078
-6,986
-3% -$372K 2.19% 8
2016
Q1
$10.3M Buy
204,064
+177
+0.1% +$8.67K 2.57% 7
2015
Q4
$10.3M Sell
203,887
-3,903
-2% -$197K 2.53% 8
2015
Q3
$9.79M Sell
207,790
-8,389
-4% -$446K 2.15% 9
2015
Q2
$11.7M Sell
216,179
-19,407
-8% -$1.09M 2.37% 8
2015
Q1
$12.9M Buy
235,586
+76,817
+48% +$4.35M 2.37% 7
2014
Q4
$8.6M Sell
158,769
-4,723
-3% -$263K 1.57% 17
2014
Q3
$9.25M Sell
163,492
-1,781
-1% -$100K 1.74% 17
2014
Q2
$9.12M Buy
165,273
+501
+0.3% +$27.3K 1.85% 14
2014
Q1
$8.93M Buy
164,772
+1,334
+0.8% +$69.1K 1.87% 14
2013
Q4
$7.8M Buy
163,438
+748
+0.5% +$34.2K 1.67% 16
2013
Q3
$7.39M Sell
162,690
-418
-0.3% -$19.1K 1.74% 14
2013
Q2
$7.23M Buy
+163,108
New +$7.29M 1.74% 14

Other funds holding MRK

Tufton Capital Management's MRK Position: Q2 2026 in Review

Tufton Capital Management reduced its Merck (MRK) stake by 0.87% in Q2 2026, selling an estimated $101K and leaving 98,272 shares worth $12.6M. The position accounts for 2.12% of the portfolio, ranked #13.

Tufton Capital Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.6M in Q4 2019. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Tufton Capital Management held 98,272 shares of Merck worth $12.6M as of Q2 2026.
  • Tufton Capital Management sold 860 Merck shares in Q2 2026, an estimated $101K.
  • Merck made up 2.12% of Tufton Capital Management's portfolio in Q2 2026, its #13 holding.
  • Tufton Capital Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Tufton Capital Management's Merck position peaked at $15.6M in Q4 2019.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Tufton Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.